Montreal Classification — Crohn's Disease
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Classified—
The Montreal Classification — Crohn's Disease calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include age group. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Montreal classification of Crohn's disease (2005): Age at diagnosis (A1 ≤16, A2 17-40, A3 >40), Location (L1 ileal, L2 colonic, L3 ileocolonic, L4 isolated upper GI modifier), Behavior (B1 non-stricturing/non-penetrating, B2 stricturing, B3 penetrating, p perianal modifier).
Clinical Indication
The Montreal Classification — Crohn's Disease is indicated for bedside clinical practice to support Montreal classification of Crohn's disease (2005): Age at diagnosis (A1 ≤16, A2 17-40, A3 >40), Location (L1 ileal, L2 colonic, L3 ileocolonic, L4 isolated upper GI modifier), Behavior (B1 non-stricturing/non-penetrating, B2 stricturing, B3 penetrating, p perianal modifier).. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy.
Montreal = A + L (+L4) + B (+p). Descriptive classification, not a score.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age_group | string | Yes | Age at diagnosis |
| location | string | Yes | Disease location |
| upper_gi | string | No | Isolated upper GI involvement (L4 modifier) |
| behavior | string | Yes | Disease behavior |
| perianal | string | No | Perianal disease modifier |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| — | Classified | Montreal Crohn's phenotype |
Evidence-Based References (EBM)
- Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5A-36A.